Want to join the conversation?
$MRK said that U.S. FDA has accepted to review Samsung Bioepis' Biologics License Application (BLA) for SB2 (infliximab), an investigational biosimilar candidate of Remicade. The application seeks approval for use in all therapeutic indications currently approved for Remicade for which marketing exclusivity has expired.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?